GLP-1 medications for weight loss, like Wegovy, are prohibitively expensive and we can’t afford to prescribe the medication for everyone who is eligible and keep them on it long-term.
A comprehensive approach to weight management. This is covered in the fifth part of Omada’s video blog series with Chief Medical Officer Carolyn Bradner Jasik, MD as she overviews what benefit buyers should consider.